Isolated Hepatic Perfusion for Extensive Liver Cancers

Surgery of the Liver, Biliary Tract and Pancreas: Volumes 1-2, Fourth Edition

Volumn 2, Issue , 2006, Pages 1312-1320

  Ku, Y ^a  

^a KOBE UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84896547421     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-3256-4.50097-1     Document Type: Chapter

References (32)

1. KR Aigner, et al. (1988) Isolated liver perfusion with MMC/5-FU: surgical technique, pharmacokinetics, clinical results. Contrib Oncol 29 229-246.
2. HR Alexander Jr, et al. (1998) Isolated hepatic perfusion with tumor necrosis factor and melphalan for unresectable cancers confined to the liver. J Clin Oncol 16 1479-1489.
3. HR Alexander Jr, et al. (2000) A phase I-II study of isolated hepatic perfusion using melphalan with or without tumor necrosis factor for patients with ocular melanoma metastatic to liver. Clin Cancer Res 6 3062-3070.
4. RK Ausman (1961) The development of a technique for isolated perfusion of the liver. New York State J Med 61 3393-3397.
5. WC Barker, et al. (1995) Continuous intraoperative external monitoring of perfusate leak using I-131 human serum albumin during isolated perfusion of the liver and limbs. Eur J Nucl Med 22 1242-1248.
6. DL Bartlett, et al. (2001) Isolated hepatic perfusion for unresectable hepatic metastases from colorectal cancer. Surgery 129 176-187.
7. MV Beheshti, et al. (1992) Percutaneous isolated liver perfusion for treament of hepatic malignancy: preliminary report. J Vasc Interv Radiol 3 1461-1572.
8. O Creech Jr, et al. (1958) Chemotherapy of cancer: regional perfusion utilizing an extracorporeal circuit. Ann Surg 148 616-632.
9. SA Curley, et al. (1993) Reduction of systemic drug exposure following hepatic arterial infusion of doxorubicin with complete hepatic venous isolation and extracorporeal chemofiltration. Surgery 114 579-585.
10. SA Curley, et al. (1994) Complete hepatic venous isolation and extracorporeal chemofiltration as treatment for human hepatocellular carcinoma: a phase I study. Ann Surg Oncol 1 389-399.
11. MR de Vries, et al. (1995) Soluble TNF-alpha receptor induction by isolated hepatic perfusion with TNF-alpha and melphalan. Eur Surg Res 27 108A.
12. MR de Vries, et al. (1998) Isolated hepatic perfusion with tumor necrosis factor alpha and melphalan: experimental studies in pigs and phase Is data from humans. Recent Results Cancer Res 147 107-119.
13. ED Feldman, et al. (2004) Regional treatment options for patients with ocular melanoma metastatic to the liver. Ann Surg Oncol 11 290-297.
14. ED Feldman, et al. (2004) Treatment of patients with unresectable primary hepatic malignancies using hyperthermic isolated hepatic perfusion. J Gastrointest Surg 8 200-207.
15. LR Hafström and PLJ Naredi (1998) Isolated hepatic perfusion with extracorporeal oxygenation using hyperthermia TNF-alpha and melphalan: Swedish experience. Recent Results Cancer Res 147 120-126.
16. LR Hafström, et al. (1994) Isolated hyperthermic liver perfusion with chemotherapy for liver malignancy. Surg Oncol 3 103-108.
17. WJ Hwu, et al. (1999) A clinical-pharmacological evaluation of percutaneous isolated hepatic infusion of doxorubicin in patients with unresectable liver tumors. Oncol Res 11 529-537.
18. Y Ku, et al. (1990) Extracorporeal removal of anticancer drugs in hepatic arterial infusion: the effect of direct hemoperfusion combined with veno-venous bypass. Surgery 107 273-281.
19. Y Ku, et al. (1995) Clinical pilot study on high-dose intraarterial chemotherapy with direct hemoperfusion under hepatic venous isolation in patients withadvanced hepatocellular carcinoma. Surgery 117 510-519.
20. Y Ku, et al. (1997) Single catheter technique of hepatic venous isolation and extracorporeal charcoal hemoperfusion for malignant liver tumors. Am J Surg 173 103-109.
21. Y Ku, et al. (1998) Induction of long-term remission in advanced hepatocellular carcinoma with percutaneous isolated liver chemoperfusion. Ann Surg 227 519-526.
22. Y Ku, et al. (2003) Percutaneous isolated hepatic perfusion for advanced hepatocellular carcinoma established with the aid of interventional radiology technique. Geka 65 1158-1167.
23. Y Ku, et al. (2004) Reductive surgery plus percutaneous isolated hepatic perfusion for multiple advanced hepatocellular carcinoma. Ann Surg 239 53-60.
24. D Lienard, et al. (1992) High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma. J Clin Oncol 10 52-60.
25. A Marinelli, et al. (1996) Phase I/II studies of isolated hepatic perfusion with mitomycin C or melphalan in patients with colorectal hepatic metastases. Jpn J Clin Oncol 26 341-350.
26. RC Miller, et al. (1994) Interaction of hyperthermia and chemotherapy agents: cell lethality and oncogenic potential. Int J Hyperthermia 10 89-99.
27. KJ Oldhafer, et al. (1998) First experience and technical aspects of isolated liver perfusion for extensive liver metastasis. Surgery 123 622-631.
28. TS Ravikumar, et al. (1994) Percutaneous hepatic vein isolation and high-dose hepatic arterial infusion chemotherapy for unresectable liver tumors. J Clin Oncol 12 2723-2736.
29. C Ruegg, et al. (1998) Evidence for the involvement of endothelial cell integrin alphaVbeta 3 in the disruption of the tumor vasculature induced by TNF and IFN-gamma. Nat Med 4 408-414.
30. K Schwemmle, et al. (1987) Rationale and indications for perfusion in liver tumors: current data. World J Surg 11 534-540.
31. M Tominaga, et al. (2004) Kobe strategy with reductive hepatectomy plus percutaneous isolated hepatic perfusion for multiple advanced hepatocellular carcinoma. Syoukakika 39 229-235.
32. AL Vahrmeijer, et al. (2000) Increased local cytostatic drug exposure by isolated hepatic perfusion: a phase I clinical and pharmacologic evaluation of treatment with high dose melphalan in patients with colorectal cancer confined to the liver. Br J Cancer 82 1539-1546.